Table 1.
Basic clinical information of elderly patients with DLBCL
| Characteristics | n (%) |
|---|---|
| Gender | |
| male | 67 (50.4) |
| female | 66 (49.6) |
| ECOG PS score | |
| 0-1 | 105 (78.9) |
| ≥2 | 28 (21.1) |
| Ann Arbor stage | |
| I-II | 79 (59.4) |
| III-IV | 54 (40.6) |
| Bulky | |
| absence | 122 (91.7) |
| presence | 11 (8.3) |
| B symptoms | |
| absence | 117 (87.9) |
| presence | 16 (12.1) |
| LDH | |
| normal | 75 (56.4) |
| elevated | 58 (43.6) |
| Liver invasion | |
| no | 125 (93.9) |
| yes | 8 (6.1) |
| CNS invasion | |
| no | 113 (84.9) |
| yes | 20 (15.1) |
| Bone marrow invasion | |
| no | 105 (78.9) |
| yes | 28 (21.1) |
| IPI score | |
| LR/LIR | 85 (63.9) |
| HIR/HR | 48(36.1) |
| ASCT | |
| no | 128 (96.2) |
| yes | 5 (3.8) |
| GNRI | |
| <82 | 15 (11.3) |
| 82-92 | 26 (19.5) |
| 92-98 | 28 (21.1) |
| >98 | 64 (48.1) |
Note: DLBCL: Diffuse Large B‐Cell Lymphoma; ECOG PS score: Eastern Cooperative Oncology Group performance status score; LDH: lactic dehydrogenase; CNS invasion: Central nervous system invasion; IPI: International Prognostic Index; LR: low risk; LIR: low intermediate risk; HIR: high intermediate risk; HR: high risk; ASCT: Autologous stem cell transplantation.